Stocks To Buy Now

Blog


Latitude 360, Inc. (LATX) Enters Burgeoning Daily Fantasy Sports Market with “360 Fantasy Live”

Latitude 360, the “ultimate upscale multi-dimensional entertainment eatery,” just announced the official launch of its 360 Fantasy Live platform at www.360fantasylive.com, just in time for the official start of the 2015 NFL season next week.

Users can now register on the 360 Fantasy Live site and participate in exciting and competitive daily fantasy contests ranging from free competitions to wagered events with chances to win big money every day.

Other exciting competitions include daily Major League Baseball contests, which are immediately available, and NFL season contests that will start shortly thereafter on Monday, September 7.

360 Fantasy Live dramatically elevates the sports watching experience while intensifying the overall dynamic Latitude 360 entertainment concept. In addition to appealing to national daily fantasy sports enthusiasts, 360 Fantasy Live will be activated within Latitude 360’s dining and entertainment venues, providing a substantial enhancement to guests who can participate in a daily fantasy contest while watching their players perform on huge HD screens.

“We are excited about bringing 360 Fantasy Live to patrons as well as those who never heard about our venues. This platform is special and our expectations are very high because it allows everyone to continue the Latitude 360 experience after leaving one of our locations,” stated Brent Brown, CEO of Latitude 360.

For more information on Latitude 360, visit www.latitude360.com

Let us hear your thoughts: Latitude 360, Inc. Message Board

From Our Blog

Nutriband Inc. (NASDAQ: NTRB) Innovating Abuse-Deterrent Drug Delivery in a Shifting Opioid Landscape

May 9, 2025

A Market Demanding Safer Opioid Solutions The opioid crisis remains a critical public health challenge in the U.S. and globally, prompting a series of new regulatory measures designed to improve safety and reduce misuse. In early 2025, the FDA approved Journavx (suzetrigine), a first-in-class non-opioid painkiller offering patients safer alternatives to opioids. Additionally, opioid manufacturers […]

Rotate your device 90° to view site.